Hutchin Hill Capital’s Medicines Co MDCO Stock Holding History

Hutchin Hill Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-21,700	Closed	-$608K	–	867
2015 Q1	$608K	Buy	+21,700	New	+$610K	0.02%	521
2014 Q1	–	Sell	-38,800	Closed	-$1.5M	–	774
2013 Q4	$1.5M	Buy	+38,800	New	+$1.39M	0.1%	202

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hutchin Hill Capital's MDCO Position: Q2 2015 in Review

Hutchin Hill Capital sold out of Medicines Co (MDCO) in Q2 2015, closing a stake of 21,700 shares — an estimated $608K sold.

Hutchin Hill Capital first reported a position in MDCO in Q4 2013 and held it in 2 quarters. The position peaked at $1.5M in Q4 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q2 2015.

Hutchin Hill Capital reported no remaining Medicines Co position as of Q2 2015 after selling out during the quarter.
Hutchin Hill Capital sold 21,700 Medicines Co shares in Q2 2015, an estimated $608K.
Hutchin Hill Capital first reported a position in Medicines Co in Q4 2013 and held it in 2 quarters.
Hutchin Hill Capital's Medicines Co position peaked at $1.5M in Q4 2013.
172 funds tracked by Wall St. Rank held Medicines Co as of Q2 2015.

Based on Hutchin Hill Capital's 13F filing for Q2 2015, filed 14 Aug 2015.